missing translation for 'onlineSavingsMsg'
Learn More

Human IL-4I1 Antibody, R&D Systems™
GREENER_CHOICE

Rat Monoclonal Antibody

Brand:  R&D Systems MAB56841-SP

 View more versions of this product

Product Code. 18770877

  • £146.00 / 25µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

IL-4I1 Monoclonal specifically detects IL-4I1 in Human samples. It is validated for ELISA.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

IL-4I1
Monoclonal
Unconjugated
Q96RQ9
Rat
Protein A or G purified from hybridoma culture supernatant
RUO
259307
Human
Purified
ELISA
1006209
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
FIG1, Fig-1 protein, hFIG1, IL4I1, IL4-induced protein 1, interleukin 4 induced 1, interleukin four induced 1, LAAO, L-amino-acid oxidase, LAO, UNQ636/PRO1265
Chinese hamster ovary cell line CHO-derived recombinant human IL-4I1, Met1-His567, Accession # Q96RQ9
25 μg
Primary
Reconstitute at 0.5 mg/mL in sterile PBS.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
IgG2b
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.